Summary of opinion: Dupixent, 18/09/2025 Positive
Submitted by Anonymous (not verified) on 19 September 2025 - 11:00
Summary of opinion: Dupixent, 18/09/2025 Positive
Summary of opinion: Lunsumio, 18/09/2025 Positive
Submitted by Anonymous (not verified) on 19 September 2025 - 11:00
Summary of opinion: Lunsumio, 18/09/2025 Positive
Human medicines European public assessment report (EPAR): Atropine sulfate FGK, atropine, Status: Opinion
Submitted by Anonymous (not verified) on 19 September 2025 - 11:00
Human medicines European public assessment report (EPAR): Atropine sulfate FGK, atropine, Status: Opinion
Summary of opinion: Keytruda, 18/09/2025 Positive
Submitted by Anonymous (not verified) on 19 September 2025 - 11:00
Summary of opinion: Keytruda, 18/09/2025 Positive
Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date of authorisation: 26/09/2017, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 19 September 2025 - 11:00
Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date of authorisation: 26/09/2017, Revision: 16, Status: Authorised
Summary of opinion: Keytruda, 18/09/2025 Positive
Submitted by Anonymous (not verified) on 19 September 2025 - 11:00
Summary of opinion: Keytruda, 18/09/2025 Positive
Antimicrobial Sales and Use (ASU) Platform: Release notes
Submitted by Anonymous (not verified) on 19 September 2025 - 10:22
Antimicrobial Sales and Use (ASU) Platform: Release notes
Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) dataload friendly file including deprecated terms
Submitted by Anonymous (not verified) on 19 September 2025 - 9:23
Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) dataload friendly file including deprecated terms
EMA Cancer Medicines Forum (CMF) meeting with industry stakeholders on cancer treatment optimisation, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 November 2025, 13:30 (CET) to 14 November 2025, 17:30 (CET)
Submitted by Anonymous (not verified) on 19 September 2025 - 9:21
EMA Cancer Medicines Forum (CMF) meeting with industry stakeholders on cancer treatment optimisation, Online, European Medicines Agency, Amsterdam, the Netherlands, from 14 November 2025, 13:30 (CET) to 14 November 2025, 17:30 (CET)
The procedure to be followed when a batch of a vaccine finished product is suspected to be contaminated with bovine viral diarrhoea virus - Scientific guideline
Submitted by Anonymous (not verified) on 19 September 2025 - 8:59
The procedure to be followed when a batch of a vaccine finished product is suspected to be contaminated with bovine viral diarrhoea virus - Scientific guideline